Interferon-Beta-1a (FP-1201) to Prevent Toxicities After CD19-Directed CAR T-Cell Therapy

Name: Interferon-Beta-1a (FP-1201) to Prevent Toxicities After CD19-Directed CAR T-Cell Therapy
License: Public Domain

Fred Hutchinson Cancer Center

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

recurrent b acute lymphoblastic leukemia, recurrent b-cell non-hodgkin lymphoma, refractory b acute lymphoblastic leukemia, refractory b-cell non-hodgkin lymphoma, recurrent mantle cell lymphoma, refractory mantle cell lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 279528
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.